Enjoy the holiday break

It's been a busy summer here at Fierce. We've been working hard to bring you content you enjoy. Also, thanks to all our readers who completed our recent survey -- your feedback has been invaluable. 

We've also heard from you in other ways. Our Top 15 Bestselling Drugs of 2008 feature delivered our best readership day ever. We have much more coming this fall that we're sure you'll enjoy. We'll be taking the holiday break to re-energize and will return to our regular publishing schedule on Tuesday, September 8. - Calisha

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.